HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kiyosumi Shibata Selected Research

Hepatocellular Carcinoma (Hepatoma)

1/2014Significant clinical response of progressive recurrent ovarian clear cell carcinoma to glypican-3-derived peptide vaccine therapy: two case reports.
9/2011Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kiyosumi Shibata Research Topics

Disease

71Neoplasms (Cancer)
02/2021 - 01/2003
46Carcinoma (Carcinomatosis)
02/2021 - 01/2002
24Ovarian Neoplasms (Ovarian Cancer)
12/2021 - 04/2005
13Neoplasm Metastasis (Metastasis)
01/2020 - 07/2004
13Ovarian Epithelial Carcinoma
07/2019 - 04/2003
13Endometrial Neoplasms (Endometrial Cancer)
01/2018 - 08/2003
12Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2023 - 03/2008
9Adenocarcinoma
06/2016 - 01/2003
6Endometrioid Carcinoma
04/2010 - 03/2003
5Rupture
10/2014 - 01/2009
4Choriocarcinoma
01/2017 - 08/2003
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2019 - 05/2004
3Teratoma (Teratoid Tumor)
12/2019 - 01/2013
3Ascites
12/2019 - 11/2007
3Residual Neoplasm
05/2016 - 01/2012
3Lymphatic Metastasis
01/2014 - 01/2005
3Mucinous Adenocarcinoma (Mucinous Carcinoma)
11/2009 - 10/2006
2Hydatidiform Mole (Molar Pregnancy)
05/2020 - 01/2017
2Endometriosis
01/2019 - 01/2006
2Hypoxia (Hypoxemia)
07/2018 - 01/2008
2Infections
05/2018 - 10/2010
2Sarcoma (Soft Tissue Sarcoma)
03/2018 - 01/2015
2Death (Near-Death Experience)
02/2017 - 04/2015
2Melanoma (Melanoma, Malignant)
09/2014 - 02/2010
2Lung Neoplasms (Lung Cancer)
09/2014 - 04/2010
2Hepatocellular Carcinoma (Hepatoma)
01/2014 - 09/2011
2Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2013 - 05/2012
1Warts (Wart)
11/2023
1Pre-Eclampsia (Preeclampsia)
01/2022
1Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational)
05/2020

Drug/Important Bio-Agent (IBA)

14Paclitaxel (Taxol)FDA LinkGeneric
11/2017 - 11/2004
13Proteins (Proteins, Gene)FDA Link
01/2020 - 04/2003
11Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
02/2010 - 05/2002
10EnzymesIBA
05/2011 - 04/2003
10Complementary DNA (cDNA)IBA
11/2009 - 04/2003
9Peptides (Polypeptides)IBA
01/2016 - 03/2003
8Carboplatin (JM8)FDA LinkGeneric
05/2020 - 11/2004
8Cisplatin (Platino)FDA LinkGeneric
05/2020 - 03/2006
8PlatinumIBA
01/2020 - 11/2004
8ParaffinIBA
12/2019 - 01/2004
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2018 - 12/2003
8Angiotensin IIIBA
05/2011 - 08/2003
7leucyl-cystinyl aminopeptidaseIBA
12/2021 - 04/2003
7Small Interfering RNA (siRNA)IBA
05/2020 - 01/2007
7GlypicansIBA
09/2014 - 01/2010
6Formaldehyde (Formol)FDA Link
12/2019 - 01/2004
6Indicators and Reagents (Reagents)IBA
07/2018 - 04/2008
5Cadherins (E-Cadherin)IBA
03/2013 - 05/2003
4AminopeptidasesIBA
01/2022 - 12/2003
4Biomarkers (Surrogate Marker)IBA
12/2021 - 03/2014
4Capsules (Microcapsules)IBA
10/2014 - 12/2011
4AntigensIBA
09/2014 - 08/2011
4Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
06/2010 - 04/2008
4Neprilysin (Neutral Endopeptidase)IBA
03/2005 - 04/2003
4Oxytocin (Pitocin)FDA LinkGeneric
08/2004 - 04/2003
3Protein Subunit VaccinesIBA
02/2021 - 01/2014
3MicroRNAs (MicroRNA)IBA
02/2021 - 08/2014
3SpectrinIBA
05/2020 - 01/2012
3ubenimexIBA
03/2008 - 05/2007
3Chemokine CXCL12IBA
01/2008 - 07/2004
3Endothelin-1 (Endothelin 1)IBA
03/2005 - 08/2004
3Leucyl Aminopeptidase (Peptidase S)IBA
01/2005 - 08/2003
3Peptide Hydrolases (Proteases)FDA Link
08/2004 - 05/2004
3Glutamyl Aminopeptidase (Aspartyl Aminopeptidase)IBA
08/2004 - 08/2003
2AcidsIBA
11/2023 - 03/2018
2Peptide Hormones (Polypeptide Hormones)IBA
01/2022 - 01/2004
2Hormones (Hormone)IBA
01/2022 - 04/2013
2ChemokinesIBA
01/2019 - 01/2007
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 05/2016
2Plasminogen Activators (Plasminogen Activator)IBA
01/2019 - 01/2008
2Messenger RNA (mRNA)IBA
03/2018 - 01/2008
2Fluorouracil (Carac)FDA LinkGeneric
01/2017 - 06/2008
2Metalloproteases (Metalloproteinases)IBA
08/2014 - 05/2004
2Fibronectins (Fibronectin)IBA
08/2014 - 02/2009
2taxaneIBA
01/2014 - 10/2012
2Basic Helix-Loop-Helix Transcription FactorsIBA
02/2013 - 01/2006
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2011 - 03/2006
2Type 1 Angiotensin ReceptorIBA
05/2011 - 04/2005
2Glucose (Dextrose)FDA LinkGeneric
10/2010 - 01/2007
2ProdrugsIBA
02/2010 - 02/2008
2paclitaxel 2'-ethylcarbonateIBA
02/2010 - 02/2008
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2009 - 03/2005
2Matrix Metalloproteinases (MMPs)IBA
01/2009 - 05/2003
2CD13 Antigens (Alanine Aminopeptidase)IBA
03/2008 - 05/2007
2ethyl monochloroacetate (EMCA)IBA
01/2007 - 07/2004
2AngiotensinsIBA
03/2006 - 01/2005
2Conditioned Culture MediaIBA
03/2005 - 01/2005
1Oncogene Proteins (Oncogene Protein)IBA
11/2023
1Caspase 3 (Caspase-3)IBA
11/2023

Therapy/Procedure

20Drug Therapy (Chemotherapy)
02/2021 - 11/2004
13Therapeutics
02/2021 - 04/2005
5Lymph Node Excision (Lymph Node Dissection)
07/2020 - 06/2008
5Radiotherapy
07/2018 - 03/2008
4Hysterectomy
05/2020 - 01/2006
4Cytoreduction Surgical Procedures
01/2019 - 01/2006
3Chemoradiotherapy
01/2017 - 05/2016
2Cystectomy
07/2019 - 04/2013
2Immunotherapy
09/2014 - 09/2011
2Adjuvant Chemotherapy
09/2012 - 12/2011
1Traditional Medicine (Folk Remedies)
11/2023